Respiratory & Pulmonary System

The main function of the respiratory system (also known as the pulmonary system) is to supply the body with oxygen and rid it of carbon dioxide. This process also removes metabolic wastes and maintains the pH balances of the body. The organs involved are the airways, lungs, and muscles that mediate the movement of air into and out of the body. When you breathe, air comes in through the mouth and nose. It passes through the larynx, also known as the voice box, and enters the chest cavity through the trachea. The trachea then splits into two tubes called bronchi, each of which leads into a lung. The airways become progressively smaller and at the end are small sacs known as alveoli, which are surrounded by capillaries. The oxygen from the air moves into the alveoli. Carbon dioxide moves through the same path in the opposite direction and is exhaled.

Asthma

Asthma is a disease that affects the tubes that bring air to and from the lungs, called airways. The airway tubes, the trachea, bronchi and bronchioles, are surrounded by muscles that can contract, narrowing the tubes and thereby making it difficult to breathe. An asthma attack is an acute narrowing of the tubes in response to exposure to an allergen (like pollen, dust and animal dander), an irritant (like cigarette smoke, pollution and cold air) or even just exercise. When the airways become inflamed, they can also swell and aggravate or sensitize the person to asthma. It is not clear as to what causes people to be prone to asthma, but heredity and environmental factors play a role. According the NIH, nearly 22.9 million people have asthma.

Company Product Phase  
Valeant Pharmaceuticals International Budefarma M Asthma
DEY LP Cromolyn sodium M Asthma
Amphastar Pharmaceuticals Inc Epinephrine Mist CFC M Asthma
DEY LP Metaproterenol sulfate M Asthma
BioMarin Pharmaceutical Inc Orapred M Asthma
BioMarin Pharmaceutical Inc Orapred ODT M Asthma
Amphastar Pharmaceuticals, Inc. Primatene M Asthma
Genentech Inc Xolair M Asthma
DEY LP Zyflo M Asthma
DEY LP Zyflo CR M Asthma
AXM Pharma Inc Afaxin M Respiratory Diseases (General)
Valeant Pharmaceuticals International Budefarma M Respiratory Diseases (General)
Valeant Pharmaceuticals International Trimexine M Respiratory Diseases (General)
Genentech, Inc. Xolair (Liquid formulation) III Asthma
Medinox, Inc. Norathiol II Acute Respiratory Distress Syndrome
Aerovance, Inc. Aerovant II Asthma
Amgen Inc AMG317 II Asthma
Amgen Inc Enbrel II Asthma
Theravance Inc GSK159802 II Asthma
Theravance Inc GSK642444 with GW685698 II Asthma
Genentech Inc HAE1 II Asthma
APT Pharmaceuticals Inc. Hydroxychloroquine APT II Asthma
Inverseon, Inc. INV102 II Asthma
KaloBios Pharmaceuticals Inc KB002 II Asthma
KaloBios Pharmaceuticals, Inc. KB002 II Asthma
KaloBios Pharmaceuticals Inc KB003 II Asthma
Genentech, Inc. MILR1444A II Asthma
MediciNova Inc MN221 II Asthma
Theravance Inc TD3327 II Asthma
Genentech, Inc. TNX650 II Asthma

Bronchospasm

Bronchospasm is characterized by difficulty breathing due to the sudden constriction of the bronchi or bronchioles in the lungs. The constriction causes the airways to narrow and mucous production to increase, reducing the flow of air into the lungs and oxygen available to the body, which causes breathlessness, coughing and hypoxia. Bronchospasm usually accompanies asthma, chronic bronchitis, anaphylaxis and as a side effect of the drugs such as Pilocarpine or even aspirin.

Company Product Phase  
DEY LP AccuNeb M Bronchospasm
Watson Pharmaceuticals Inc Albuterol M Bronchospasm
Amphastar Pharmaceuticals Inc Albuterol CFC M Bronchospasm
DEY LP Albuterol sulfate M Bronchospasm
Watson Pharmaceuticals Inc Albuterol sulfate M Bronchospasm
DEY L.P. DuoNeb M Bronchospasm
Auriga Laboratories Inc Extendryl PSE M Bronchospasm
DEY LP Ipratropium bromide M Bronchospasm
Watson Pharmaceuticals Inc Ipratropium bromide, Albuterol sulfate M Bronchospasm
DEY LP Metaproterenol sulfate M Bronchospasm
Impax Laboratories Inc Terbutaline sulfate M Bronchospasm

Chronic Obstructive Pulmonary Disease (COPD)

Chronic obstructive pulmonary disease, or COPD, is a lung disease in which the lung is damaged, making it hard to breathe. In COPD, the airways that carry air in and out of your lungs become partially blocked, making it difficult to get air in and out. COPD is a major cause of death and illness throughout the world. According to the NIH, it is the 4th leading cause of death in the U.S. and the world.

Company Product Phase  
Proteo Inc Elafin PROTEO II Chronic Obstructive Pulmonary Disease
Theravance Inc GSK159802 II Chronic Obstructive Pulmonary Disease
Theravance Inc GSK642444 II Chronic Obstructive Pulmonary Disease
Mpex Pharmaceuticals MP376 II Chronic Obstructive Pulmonary Disease
Theravance Inc TD3327 II Chronic Obstructive Pulmonary Disease
Theravance Inc TD5959 II Chronic Obstructive Pulmonary Disease

Cough

Coughing is the body's way of removing foreign material or mucus from the airway tubes. Coughs have distinctive traits that can be recognized. A cough is only a symptom, not a disease and often the importance of the cough can be determined only when other signs and symptoms are evaluated.

Company Product Phase  
Watson Pharmaceuticals Inc Dextromethorphan hydrobromide with Guaifenesin Extended Release PA Cough
Watson Pharmaceuticals Inc Guaifenesin ER PA Cough
Watson Pharmaceuticals Inc Guaifenesin, Pseudoephedrine hydrochloride WATSON PA Cough
Valeant Pharmaceuticals International Aflegan M Cough
AXM Pharma Inc Benproperine phosphate M Cough
Valeant Pharmaceuticals International Breacol M Cough
Lee Pharmaceuticals Cheracol Plus M Cough
Lee Pharmaceuticals Cheracol-D M Cough
BIO-VED Pharmaceuticals Inc Corshe M Cough
Lee Pharmaceuticals Creo-Terpin M Cough
Lee Pharmaceuticals Creo-Terpin M Cough
Valeant Pharmaceuticals International Ethylmorphine M Cough
Valeant Pharmaceuticals International Eurespal M Cough
Auriga Laboratories Inc Extendryl DM M Cough
Auriga Laboratories Inc Extendryl GCP M Cough
Auriga Laboratories Inc Extendryl HC M Cough
Watson Pharmaceuticals Inc Guaifenesin M Cough
Watson Pharmaceuticals Inc Guaifenesin DM Cough M Cough
Watson Pharmaceuticals Inc Hydropane M Cough
Watson Pharmaceuticals Inc Hydrotuss M Cough
Watson Pharmaceuticals Inc Kidkare M Cough
Auriga Laboratories Inc Levall M Cough
Valeant Pharmaceuticals International Levocof M Cough
Valeant Pharmaceuticals International Noscapine M Cough
Valeant Pharmaceuticals International Nyal M Cough
PureTek Corporation Sugar-free allergy relief M Cough
PureTek Corporation Sugar-free night time M Cough
Lee Pharmaceuticals Throat Discs M Cough
Valeant Pharmaceuticals International Trimexine M Cough

Cystic Fibrosis(CF)

Cystic fibrosis is a hereditary disease that mainly affects the lungs and digestive system, causing progressive disability and for some, early death. Formerly known as cystic fibrosis of the pancreas, this entity has increasingly been labeled simply "cystic fibrosis." Average life expectancy is around 37 years, although improvements in treatments mean a baby born today could expect to live longer.

CF is caused by a mutation in a gene called the cystic fibrosis transmembrane conductance regulator (CFTR). The product of this gene is a chloride ion channel important in creating sweat, digestive juices and mucus. Although most people without CF have two working copies of the CFTR gene, only one is needed to prevent cystic fibrosis. CF develops when neither gene works normally. Therefore, CF is considered an autosomal recessive disease. The name “cystic fibrosis” refers to the characteristic “fibrosis” (tissue scarring) and cyst formation within the pancreas, first recognized in the 1930s.

Difficulty breathing and insufficient enzyme production in the pancreas are the most common symptoms. Thick mucus production as well as a less competent immune system results in frequent lung infections, which are treated, though not always cured, by oral and intravenous antibiotics and other medications. A multitude of other symptoms, including sinus infections, poor growth, diarrhea and potential infertility (mostly in males, due to the condition Congenital bilateral absence of the vas deferens) result from the effects of CF on other parts of the body. Often, symptoms of CF appear in infancy and childhood; these include meconium ileus, too many people fail to thrive and recurrent lung infections.

Cystic fibrosis is one of the most common life-shortening, childhood-onset inherited diseases. In the U.S., 1 in 3900 children is born with CF. It is most common among Europeans and Ashkenazi Jews; one in twenty-two people of European descent carry one gene for CF, making it the most common genetic disease among such people. About 30,000 people in the United States have the disease.

Company Product Phase  
Gilead Sciences Inc Aztreonam lysine PA Cystic Fibrosis
Genentech Inc Pulmozyme M Cystic Fibrosis
Novartis AG Tobi (tobramycin) M Cystic Fibrosis
Valeant Pharmaceuticals International Deflegmin M Mucolytic Agent
DEY LP Sterile acetylcysteine M Mucolytic Agent
Aerovance Inc Aerolytic / AER 002 II Cystic Fibrosis
Aradigm Corp ARD3100 II Cystic Fibrosis
Proteo Inc Elafin PROTEO II Cystic Fibrosis

Emphysema

Emphysema is a chronic lung disease most often caused by prolonged exposure to toxic chemicals and/or tobacco smoke. It is characterized by the loss of elasticity of the lung tissue, destruction of structures supporting the alveoli (the air sacs at the end of the airways) and destruction of blood capillaries feeding the alveoli. As a result, the small airways collapse during expiration and air gets trapped in the lungs. Symptoms include shortness of breath on exertion, hyperventilation (to get more oxygen into the lungs) and an expanded chest.

Company Product Phase  
Arriva Pharmaceuticals, Inc Respriva II Emphysema

Lung Damage

Patients are often placed on high concentrations of oxygen in order to maintain proper levels of the gas in their blood. Long-term exposure to high concentrations of oxygen is toxic and can lead to decreased lung function, respiratory failure and even death. Oxidant exposure is just one of the causes of a spectrum of lung injuries that are known collectively as ARDS; other injuries that can cause this condition include trauma, infection, drug overdose, metabolic disorders and inhaled toxicants.

Nasal Congestion

Nasal congestion is a congested nose and sinuses or obstruction of the nose.

Company Product Phase  
Watson Pharmaceuticals Inc Bromaline M M Nasal congestion
Watson Pharmaceuticals Inc Bromaline DM M Nasal congestion
Valeant Pharmaceuticals International Eskornade M Nasal congestion
Auriga Laboratories Inc Extendryl G M Nasal congestion
Auriga Laboratories Inc Extendryl PEM M Nasal congestion
Watson Pharmaceuticals Inc Kidkare Decongestant Drops M Nasal congestion
Valeant Pharmaceuticals International Newclar M Nasal congestion
Watson Pharmaceuticals Inc Nrs M Nasal congestion
China Sky One Medical Inc Oxymetazoline hydrochloride M Nasal congestion
Watson Pharmaceuticals Inc Phenylephrine hydrochloride M Nasal congestion
Watson Pharmaceuticals Inc Pseudoephedrine M Nasal congestion
Valeant Pharmaceuticals International Resoxym M Nasal congestion
Valeant Pharmaceuticals International Xylometazolin M Nasal congestion
Parnell Pharmaceuticals Inc Pretz M Nasal Dryness
Watson Pharmaceuticals Inc Saline Mist M Nasal Dryness

Pulmonary Embolism

Pulmonary embolism is the blockage of a pulmonary artery in the lungs by a blood clot (thrombus), fat, air or tumor cells. The most common form is a blood clot which originated as a deep vein thrombus and traveled through the veins and right heart into the lungs. Most patients are diagnosed through pulmonary angiopathy and CT scans. Symptoms include difficulty breathing, pain during breathing and circulatory instability. The National Institutes of Health estimated at least 100,000 cases of PE occur each year in the United States.

Company Product Phase  
Genentech Inc Activase M Pulmonary Embolism

Pulmonary Fibrosis

Pulmonary fibrosis is an inflammatory lung disorder characterized by abnormal formation of fibrous tissue (fibrosis) between the tiny air sacs (alveoli) or ducts of the lungs, which affects the lungs’ ability to move oxygen into the bloodstream. Currently in the U.S. there are over 200,000 patients with pulmonary fibrosis, though the number is probably much higher due to misdiagnosis.

Company Product Phase  
Gilead Sciences Inc Letairis III Pulmonary Fibrosis
InterMune Inc Pirfenidone III Pulmonary Fibrosis

Pulmonary Hypertension

Pulmonary hypertension is high blood pressure in the arteries to the lungs. It is a serious condition for which there are treatments but no cure. If one has it, the blood vessels that carry oxygen-poor blood from the heart to the lungs become hard and narrow. The heart has to work harder to pump the blood through. Over time, the heart weakens and cannot do its job and one can develop heart failure.

Company Product Phase  
Gilead Sciences Inc Flolan M Pulmonary Hypertension
Gilead Sciences Inc Letairis M Pulmonary Hypertension
Genentech Inc Tracleer M Pulmonary Hypertension
GlaxoSmithKline Volibris (ambrisentan) M Pulmonary Hypertension
Gilead Sciences Inc Cicletanine II Pulmonary Hypertension
Proteo Inc Elafin II Pulmonary Hypertension
Aradigm Corp Tyvaso A Pulmonary Hypertension

Respiratory Distress Syndrome

Respiratory distress syndrome (RDS) is a breathing problem that sometimes affects babies born about 6 weeks or more before their due dates. Their lungs aren't developed enough to make surfactant (sur-FAK-tant). Surfactant is a liquid that coats the inside of the lungs and keeps them open so that the baby can breathe in air once he or she is born. Without surfactant, the lungs collapse and the baby has to work hard to breathe. The baby might not be able to breathe in enough oxygen to support the body's organs. Most infants who develop RDS show signs of breathing problems at birth or within the next few hours. If they're not given the right treatment, their brains and other organs may suffer from the lack of oxygen. It affects about 10 of every 100 premature infants in the United States, or about 40,000 babies, each year.

Company Product Phase  
DEY LP Curosurf M Respiratory Distress Syndrome

Respiratory Syncytal Virus

A paramyxovirus that forms in the tissue culture and is responsible for severe respiratory diseases, such as bronchopneumonia and bronchiolitis in children and especially in infants.

Company Product Phase  
Valeant Pharmaceuticals International Virazole M Respiratory Syncytial Virus (RSV) Infection


©2010 BayBio All rights reserved. 400 Oyster Point Blvd. Suite 221, South San Francisco CA 94080 | Tel: (650) 871-7101 | www.BayBio.org built@zoomedia